Literature DB >> 2342000

Postpartum blues: salivary cortisol and psychological factors.

U Ehlert1, U Patalla, C Kirschbaum, E Piedmont, D H Hellhammer.   

Abstract

The relationships between several psychological variables and salivary cortisol levels were investigated in 70 young mothers throughout the first five days following the delivery of a healthy baby. We hypothesized that postpartum blues is associated with ineffective coping strategies, high anxiety levels, and elevated salivary cortisol concentrations. Data analysis revealed that symptoms of postpartum blues occurred more frequently in women who reported high levels of trait-anxiety, passive coping strategies, marital dissatisfaction, or acceptance of their role as a mother. These women had elevated morning levels of cortisol on those days on which the symptoms appeared in contrast to those days without symptoms as well as in contrast to those women who did not experience postpartum blues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342000     DOI: 10.1016/0022-3999(90)90088-l

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  11 in total

1.  Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression.

Authors:  Marta Skrundz; Margarete Bolten; Irina Nast; Dirk H Hellhammer; Gunther Meinlschmidt
Journal:  Neuropsychopharmacology       Date:  2011-05-11       Impact factor: 7.853

2.  Stress, coping and cognitive deficits in women after surgery for breast cancer.

Authors:  Stephanie A Reid-Arndt; Cathy R Cox
Journal:  J Clin Psychol Med Settings       Date:  2012-06

3.  Hair cortisol levels as a retrospective marker of hypothalamic-pituitary axis activity throughout pregnancy: comparison to salivary cortisol.

Authors:  Kimberly L D'Anna-Hernandez; Randal G Ross; Crystal L Natvig; Mark L Laudenslager
Journal:  Physiol Behav       Date:  2011-03-21

4.  Economic Stress and Cortisol Among Postpartum Low-Income Mexican American Women: Buffering Influence of Family Support.

Authors:  Shannon L Jewell; Linda J Luecken; Jenna Gress-Smith; Keith A Crnic; Nancy A Gonzales
Journal:  Behav Med       Date:  2015       Impact factor: 3.104

Review 5.  Postnatal mental illness: a transcultural perspective.

Authors:  R Kumar
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-11       Impact factor: 4.328

Review 6.  Perinatal maternal depression and cortisol function in pregnancy and the postpartum period: a systematic literature review.

Authors:  Sunaina Seth; Andrew J Lewis; Megan Galbally
Journal:  BMC Pregnancy Childbirth       Date:  2016-05-31       Impact factor: 3.007

7.  Human milk cortisol and immune factors over the first three postnatal months: Relations to maternal psychosocial distress.

Authors:  Marina Aparicio; Pamela D Browne; Christine Hechler; Roseriet Beijers; Juan Miguel Rodríguez; Carolina de Weerth; Leonides Fernández
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

8.  The relationship between labor pain management, cortisol level and risk of postpartum depression development: a prospective nonrandomized observational monocentric trial.

Authors:  Oksana V Riazanova; Yurii S Alexandrovich; Alexander M Ioscovich
Journal:  Rom J Anaesth Intensive Care       Date:  2018-10

9.  Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment [ISRCTN08045231].

Authors:  John M Saxton; Amanda Daley; Nicola Woodroofe; Robert Coleman; Hilary Powers; Nanette Mutrie; Vanessa Siddall; Helen Crank
Journal:  BMC Cancer       Date:  2006-02-09       Impact factor: 4.430

10.  Prenatal and Postpartum Evening Salivary Cortisol Levels in Association with Peripartum Depressive Symptoms.

Authors:  Stavros I Iliadis; Erika Comasco; Sara Sylvén; Charlotte Hellgren; Inger Sundström Poromaa; Alkistis Skalkidou
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.